Raj Denhoy
Stock Analyst at Jefferies
(3.03)
# 1,435
Out of 5,090 analysts
55
Total ratings
68.09%
Success rate
24.45%
Average return
Main Sectors:
Stocks Rated by Raj Denhoy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterates: Hold | $120 | $125.08 | -4.06% | 5 | Sep 26, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $110 → $130 | $86.19 | +50.83% | 10 | Jul 30, 2021 | |
| HOLX Hologic | Maintains: Buy | $106 → $110 | $74.97 | +46.73% | 9 | Apr 5, 2021 | |
| PROF Profound Medical | Initiates: Buy | n/a | $6.60 | - | 1 | Sep 15, 2020 | |
| DXCM DexCom | Maintains: Buy | $29 → $31 | $65.49 | -52.28% | 8 | Aug 2, 2018 | |
| AXGN Axogen | Initiates: Buy | $35 | $33.32 | +5.04% | 1 | Nov 30, 2017 | |
| TFX Teleflex | Maintains: Buy | $270 → $295 | $120.50 | +144.81% | 9 | Nov 3, 2017 | |
| LIVN LivaNova | Maintains: Buy | $80 → $91 | $63.36 | +43.62% | 3 | Nov 3, 2017 | |
| LNTH Lantheus Holdings | Maintains: Buy | $22 → $27 | $63.30 | -57.35% | 2 | Nov 3, 2017 | |
| PODD Insulet | Maintains: Buy | $58 → $67 | $304.49 | -78.00% | 7 | Nov 3, 2017 |
Abbott Laboratories
Sep 26, 2024
Reiterates: Hold
Price Target: $120
Current: $125.08
Upside: -4.06%
Edwards Lifesciences
Jul 30, 2021
Maintains: Buy
Price Target: $110 → $130
Current: $86.19
Upside: +50.83%
Hologic
Apr 5, 2021
Maintains: Buy
Price Target: $106 → $110
Current: $74.97
Upside: +46.73%
Profound Medical
Sep 15, 2020
Initiates: Buy
Price Target: n/a
Current: $6.60
Upside: -
DexCom
Aug 2, 2018
Maintains: Buy
Price Target: $29 → $31
Current: $65.49
Upside: -52.28%
Axogen
Nov 30, 2017
Initiates: Buy
Price Target: $35
Current: $33.32
Upside: +5.04%
Teleflex
Nov 3, 2017
Maintains: Buy
Price Target: $270 → $295
Current: $120.50
Upside: +144.81%
LivaNova
Nov 3, 2017
Maintains: Buy
Price Target: $80 → $91
Current: $63.36
Upside: +43.62%
Lantheus Holdings
Nov 3, 2017
Maintains: Buy
Price Target: $22 → $27
Current: $63.30
Upside: -57.35%
Insulet
Nov 3, 2017
Maintains: Buy
Price Target: $58 → $67
Current: $304.49
Upside: -78.00%